Market Overview

UPDATE: Morgan Stanley Raises PT to $35 on Paychex on Organic Growth Outlook

Related PAYX
Paychex Beats Q1 Estimates, Shares Rise
Keep an Eye on These Stocks for September 30, 2015
Nintai Charitable Trust: Q3 Report (GuruFocus)

Morgan Stanley reiterated its Neutral rating on Paychex (NASDAQ: PAYX) but raised its price target from $32 to $35.

Morgan Stanley commented, "We are positive on the payroll processing sector but see less upside for PAYX due to (1) weaker cycle to cycle earnings improvement, (2) less-attractive capital allocation, and (3) slow recovery for SMB clients coming out of the downturn. … Our estimates are unchanged from our previous publishing but we increase our multiple from 19.5X as our organic growth analysis still shows nearly 20pp improvement over the previous employment cycle"

Paychex closed at $33.37 on Thursday.

Latest Ratings for PAYX

Oct 2015RBC CapitalMaintainsUnderperform
Aug 2015JP MorganMaintainsNeutral
Jul 2015Goldman SachsDowngradesBuyNeutral

View More Analyst Ratings for PAYX
View the Latest Analyst Ratings

Posted-In: Morgan StanleyAnalyst Color Price Target Pre-Market Outlook Analyst Ratings


Related Articles (PAYX)

Get Benzinga's Newsletters